219 related articles for article (PubMed ID: 20597027)
1. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
Russo RC; Garcia CC; Teixeira MM
Curr Opin Drug Discov Devel; 2010 Jul; 13(4):414-27. PubMed ID: 20597027
[TBL] [Abstract][Full Text] [Related]
2. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
Ali S; O'Boyle G; Mellor P; Kirby JA
Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
Donnelly LE; Barnes PJ
Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
[TBL] [Abstract][Full Text] [Related]
4. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
Rosenkilde MM
Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
[TBL] [Abstract][Full Text] [Related]
5. [Chemokines a hope of specific anti-inflammatory treatment].
Schedvins P; Hjelmström P
Lakartidningen; 2002 Mar; 99(10):1056-9. PubMed ID: 12024779
[TBL] [Abstract][Full Text] [Related]
6. The chemokine network: a target in cancer biology?
Slettenaar VI; Wilson JL
Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
[TBL] [Abstract][Full Text] [Related]
7. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
8. Anti-chemokine small molecule drugs: a promising future?
Proudfoot AE; Power CA; Schwarz MK
Expert Opin Investig Drugs; 2010 Mar; 19(3):345-55. PubMed ID: 20113217
[TBL] [Abstract][Full Text] [Related]
9. Chemokine blockers--therapeutics in the making?
Wells TN; Power CA; Shaw JP; Proudfoot AE
Trends Pharmacol Sci; 2006 Jan; 27(1):41-7. PubMed ID: 16310864
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection.
Thomas LH; Friedland JS; Sharland M
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):415-25. PubMed ID: 17547506
[TBL] [Abstract][Full Text] [Related]
11. Manipulating the chemokine-chemokine receptor network to treat cancer.
Ruffini PA; Morandi P; Cabioglu N; Altundag K; Cristofanilli M
Cancer; 2007 Jun; 109(12):2392-404. PubMed ID: 17503430
[TBL] [Abstract][Full Text] [Related]
12. Chemokine sequestration by atypical chemokine receptors.
Hansell CA; Simpson CV; Nibbs RJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1009-13. PubMed ID: 17073739
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptors as specific anti-inflammatory targets in peripheral nerves.
Ubogu EE
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):141-53. PubMed ID: 21476965
[TBL] [Abstract][Full Text] [Related]
14. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
[TBL] [Abstract][Full Text] [Related]
15. Microbial corruption of the chemokine system: an expanding paradigm.
Pease JE; Murphy PM
Semin Immunol; 1998 Jun; 10(3):169-78. PubMed ID: 9653043
[TBL] [Abstract][Full Text] [Related]
16. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
Haringman JJ; Oostendorp RL; Tak PP
Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
[TBL] [Abstract][Full Text] [Related]
17. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
Vielhauer V; Anders HJ; Schlöndorff D
Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
[TBL] [Abstract][Full Text] [Related]
18. Targeting the chemokine system for multiple sclerosis treatment.
Glabinsk AR; Ransohoff RM
Curr Opin Investig Drugs; 2001 Dec; 2(12):1712-9. PubMed ID: 11892933
[TBL] [Abstract][Full Text] [Related]
19. The expression and function of chemokines involved in CNS inflammation.
Ubogu EE; Cossoy MB; Ransohoff RM
Trends Pharmacol Sci; 2006 Jan; 27(1):48-55. PubMed ID: 16310865
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery and chemokine receptor antagonists: eppur si muove!
Terricabras E; Benjamim C; Godessart N
Autoimmun Rev; 2004 Nov; 3(7-8):550-6. PubMed ID: 15546804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
